The US District Court for the District of Delaware announced the settlement this week, ending the dispute, which originated as a patent infringement suit by Invitae against Natera.
The test uses autofluorescent single-walled carbon nanotubes to detect bacterial cell death in antimicrobial-containing microfluidic channels.
The US District Court for the District of Delaware announced the settlement this week, ending the dispute, which originated as a patent infringement suit by Invitae against Natera.
The grant will support the development of an automated, cartridge-based desktop testing instrument for direct-from-blood detection of yeast infections.
The private equity firms invested along with executive Cary Breese, who is slated to become CEO of the clinical lab.
The company plans to launch in 2026 a program that will provide labs with scanners free of charge in exchange for volume-based payments for biomarker tests.
The company recently published a study showing that elemental patterns in single strands of hair are different in patients ...
The agency said that during emergencies it will balance the risks of delaying access to tests compared with the risks of harm from inaccurate test results.
The firm said the investment and agreement will enhance its financial position and ally it with a leading partner in the diagnostics space.
The agency said that it will during emergencies balance the risks of delaying access to tests compared with the risks of harm from inaccurate test results.
NEW YORK — Quest Diagnostics has struck a deal to use healthcare software firm Epic Systems' suite of enterprise laboratory software and services, the companies said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback